Underwriter option for additional shares
Company: TeraWulf
What the later record shows
Outcome not yet confirmed
No passage says whether the underwriter exercised its 30-day option or whether total proceeds reached about $23.0 million.
Checked October 9, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
If underwriter fully exercises 30-day option, TeraWulf will receive approximately $23.0 million in total gross proceeds
Source (primary)
TeraWulf 424B5 filed 2022-04-13 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “If the underwriter exercises the option in full, the total proceeds to us, before expenses, will be approximately $23.0 million”
How we checked this
Checked on October 11, 2026. The cited source supports part of this claim, but not all of it.
The filing confirms the 30-day option and the roughly $23.0 million total if it is fully exercised. It describes the figure as proceeds before expenses, not as gross proceeds.
Confirmed in the source:
- The underwriter has a 30-day option to buy up to 447,894 additional shares
- If the underwriter exercises the option in full, total proceeds to TeraWulf before expenses will be approximately $23.0 million
We could not confirm this from the cited source:
- That the approximately $23.0 million is gross proceeds (the document describes it as total proceeds to the company before expenses, based on the underwriter's discounted purchase price)
That does not mean it is false — only that this source does not establish it, as of the date above. If we find a source that settles it, we will re-check and update this page.
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1083301/000110465922045550/tm2212158-3_424b5.htm) in full (258,880 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms TeraWulf 424B5 filed 2022-04-13
Quote: “If the underwriter exercises the option in full, the total proceeds to us, before expenses, will be approximately $23.0 million”
